A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease
Michio Senda(Kyoto University), Hiroyuki Shimada(National Center for Geriatrics and Gerontology), Hisatsugu Tachibana(Kobe University), Shinsuke Washizuka(Shinshu University), Takeshi Ikeuchi(Niigata University Medical and Dental Hospital), Yasuhiko Ikari(Japan Association for Development of Community Medicine), Yoshiki Niimi(University of Tokyo Hospital), Takanori Yokota(Tokyo Medical and Dental University), Toshinari Odawara(Yokohama City University), Hiroyuki Arai(The University of Tokyo), Kensaku Kasuga(Niigata University), Akira Tamaoka(University of Tsukuba), Hiroshi Matsuda(Kawamura Gakuen Women's University), Yutaka Arahata(National Center for Geriatrics and Gerontology), Yoshiaki Itoh(Osaka City University), Kenji Ishii(Tokyo Metropolitan Institute of Gerontology), Takeshi Iwatsubo(National Center of Neurology and Psychiatry), Ryoko Ihara(Tokyo Metropolitan Institute of Gerontology), Hiroshi Mori(National Institute of Genetics), E. Matsubara(Kumamoto University), Kazushi Suzuki(National Defense Medical College), Atsushi Iwata(National Center of Neurology and Psychiatry), Kengo Ito(National Center for Geriatrics and Gerontology), Kenjiro Ono(Kanazawa University), Y Ichimiya(Tokyo Metropolitan Geriatric Hospital), A. Nakanishi(Koujin Hospital)
Cited by 7
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k